Elekta announces strategic partnership with McLaren Health

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Dec 18, 2013 at 1:46 AM

Elekta announces strategic partnership with McLaren Health Care to improve cancer care in Michigan

Agreement secures full Elekta solution across the McLaren enterprise STOCKHOLM, December 18, 2013 – The ability to effectively manage data across disparate health systems to help drive quality care will be a cornerstone for health systems of the future. Elekta is proud to announce today that it has joined forces with Michigan-based McLaren Health Care to launch MOSAIQ® oncology information system throughout McLaren’s cancer network. This partnership will enable McLaren to deploy MOSAIQ to centralize patient information across radiation oncology, particle therapy and medical oncology into a single user interface, accessible by multi-disciplinary teams across McLaren’s multiple locations. “By developing a long-term agreement with McLaren, Elekta reinforces its leadership in oncology information systems,” explained Tomas Puusepp, President and CEO of Elekta. “Our collaboration with McLaren will further strengthen the integration of the entire cancer system to help improve patient care,” Puusepp added. The agreement entered today goes beyond MOSAIQ; it currently includes 15 Elekta linear accelerators, one Leksell Gamma Knife®, seven brachytherapy systems, and Monaco® treatment planning system to further drive improvements in quality and patient safety. The agreement will be booked in Elekta’s second half of fiscal year 2013-14 and is valued at more than USD 50 million. “At McLaren we are committed to delivering the best cancer care in the world. Today, McLaren is one of the largest oncology providers in the State of Michigan and one of the largest in the United States,” said Philip A. Incarnati, President and Chief Executive Officer of McLaren Health Care. “We knew we needed a global leader to help us connect our facilities in a way that allows providers to function in a multi-disciplinary fashion. Elekta is that partner,” he explained. McLaren will move to replace its current linear accelerator fleet with Elekta Versa HD™, a single system that delivers high-volume conventional techniques in addition to advanced treatments that require precise targeting. Versa HD is equipped with the Agility™ 160-leaf multileaf collimator for high-speed, high -precision beam shaping to support extremely accurate tumor targeting and to maximize the preservation of healthy tissue. “By choosing Elekta as our partner, we will be able to give our patients access to the most advanced technology for treating cancer,” said Justin Klamerus, MD, MMM, Chief Quality Officer and lead for McLaren’s community-based cancer programs. “The comprehensive solution provided by Elekta, along with McLaren’s slated opening of the Proton Therapy Center in Flint, enables our cancer program to become one of the most advanced radiation oncology providers in the world,” highlighted Klamerus. “We have spent 18 months exploring this partnership and we are confident that Elekta will help us transform cancer care for our patients. No mission is greater than this,” he added. # # # For further information, please contact: Johan Andersson, Director, Investor Relations, Elekta AB Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com Time zone: CET: Central European Time Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta Tel: +1 770-670-2447, e-mail: michelle.joiner@elekta.com Time zone: ET: Eastern Time The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on December 18, 2013. About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO: EKTAB. Website: www.elekta.com. About McLaren Health Care McLaren Health Care, a 501(c)3 nonprofit organization, is a large, clinically integrated health delivery system that includes 11 hospitals, ambulatory surgery centers, imaging centers, the state’s only proton therapy center, the state’s largest network of cancer centers and providers, an employed primary care physician network, assisted living facilities, commercial and Medicaid HMOs, home health care and hospice, durable medical equipment, retail pharmacy services, and a wholly-owned medical malpractice insurance company. McLaren’s current cancer care delivery network has 16 locations, treating in excess of 12,000 of Michigan’s 57,500 newly diagnosed cancer cases. McLaren’s network includes an NCI-designated comprehensive cancer center. More information at www.mclaren.org.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Data Center Piping Surges With AI Cooling to $4.5B

Liquid Cooling Revolutionizes Data Center Infrastructure Gotta hand it to the tech world, when it decides to shift, it shifts hard and fast. The data center piping market isn't just keeping up—it's sprinting. The move towards liquid-cooled AI setups isn’t just a trend; it’s a defining transformation. With a projected explosion to a $4.5 billion market by 2035, you...

AI Campuses Drive Surge in Power Cable Market

Surge in Data Center Power Cable Demand Walking down the old data center aisle, you'd never imagine so much copper snaking its way into the modern megalith of AI campuses. But here we are, staring at a market projected to leap from USD 1.74 billion in 2025 to a whopping USD 4.72 billion by 2035. That's a compounded annual growth rate (CAGR) of a robust 10.50%, and it’s...

Rocket Companies' Earnings Preview: What's at Stake?

Anticipation Builds Around Rocket's Earnings Call It ain't every day that a company's earnings announcement stirs up interest the way Rocket Companies' (NYSE:RKT) upcoming third-quarter results have. But here we are, just days away from October 29, 2026, when leadership will lay out the cards at 4:30 p.m. ET. This announcement might just be what investors like us need to...

AMTD Digital's Half-Year Results Stir Investor Interest

AMTD Digital Warming Up for a Busy Quarter Some things just catch the wind differently in the market, and when a heavyweight like AMTD Digital starts talking numbers, everybody perks up. They're gearing up to drop their half-year financials, ready to roll out at the stroke of midnight on October 23rd, and investor ears across the globe are pricked for what’s coming down...

Vertice P2P Aims to Transform Procurement Efficiency

Vertice Dives Deeper into the Procurement Game Grab a coffee and let's talk some procurement—one of the least sexy, yet utterly essential parts of any operation. Vertice's latest announcement is anything but mundane. They're spiraling deeper into the procurement universe with their new Procure-to-Pay (P2P) capability, a bold expansion from their Intake-to-Procure (I2P)...

Lunai Bioworks Voluntarily Delists After Equity Snags

Bracing for the Delisting Impact Well, isn't that a familiar tune? Lunai Bioworks Inc., ticking with the symbol NASDAQ:LNAI, is pulling the plug on its Nasdaq listing faster than a kid yanking out a loose tooth. On October 21, 2026, the company's board decided it's cheaper and simpler to step off the dance floor than keep paying for a spot when the music's stopped....

Centrus Energy to Discuss Q3 Earnings on Nov 5 Call

Centrus Energy Prepares for Earnings Call You ever feel that twinge in your gut right before a big disclosure? Well, that's where Centrus Energy’s about to take us as they gear up for their quarterly earnings call. On November 5th, bright and early at 8:30 a.m. Eastern Time, NYSE:LEU will be in the spotlight, laying out its Q3 results for all us nose-to-the-grindstone...

Venture Dock Fosters Global Startup Ecosystems

Venture Dock Connects the Global Startup Dots When it comes down to bridging the gap between promising innovation and commercial success, you'd be hard-pressed to find a better player than Venture Dock. In a world filled with buzzwords and fluff, these guys are socketed deep in the guts of genuine startup development — and they're making waves with their recent...

Beggin' Unveils Festive Treats for Canine Thanksgiving

Dog Treats That Spice Up Thanksgiving Feast Just when you thought Thanksgiving was all about the humans crowding around a table of turkey and stuffing, Beggin' decides to throw the dogs a bone—literally. These guys rolled out their limited-edition holiday treats that’ll probably have your pup sniffin’ the air like it’s the early days of autumn. What's Cookin' In...

PENNVEST Grants $42M for PA Water Upgrades

Big Boost for Pennsylvania's Water Infrastructure The recent announcement about Pennsylvania American Water scoring a $42 million package from PENNVEST feels like a solid win for everyone except complacency. This move is a direct nod to infrastructure sorely needing an upgrade in Lackawanna and Montgomery counties. You'd think these improvements were long overdue with all...